Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01736618 · ClinicalTrials.gov registry record
S-ICD® System Post Approval Study
A clinical trial, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- 1,766
- Enrollment target
NCT01736618: Completed study, sponsored by Boston Scientific Corporation.
NCT01736618 is a clinical trial that has completed, run by Boston Scientific Corporation. The registered enrollment target is 1,766 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01736618 has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- 1,766 participants
- Enrollment target
Study Summary
The purpose of the S-ICD Post Approval Study is to document long term safety and effectiveness outcomes associated with the implantation of the SQ-RX pulse generator and Q-TRAK electrode in a commercial clinical setting.
Primary Outcome
Type I complications are adverse events caused by a component of the S-ICD System (i.e. pulse generator, electrode, EIT or programmer) that results in permanent loss of device function, invasive intervention or death.
Interventions
- DEVICE S-ICD System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,766 participants |
| Start Date | 2013-03-12 |
| Est. Completion | 2021-10-15 |
What the finished NCT01736618 record still lists
NCT01736618 is an observational study that tracks outcomes without assigning an intervention. Its 1,766 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which S-ICD System is the first listed.
NCT01736618 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01736618 about?
NCT01736618 is a clinical study titled "S-ICD® System Post Approval Study". The purpose of the S-ICD Post Approval Study is to document long term safety and effectiveness outcomes associated with the implantation of the SQ-RX pulse generator and Q-TRAK electrode in a commercial clinical setting.
What is the current status of trial NCT01736618?
This trial is currently completed. The enrollment target is 1,766 participants. The study started on 2013-03-12. Estimated completion is 2021-10-15.
What interventions are being tested in trial NCT01736618?
The interventions under investigation include: S-ICD System (DEVICE).
Who is sponsoring clinical trial NCT01736618?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06239688 · 1,764 participants · NA
Evaluating a National Person-Centered Training Program to Strengthen the Dementia Care Workforce
- NCT06872892 · 1,755 participants · Phase 3
The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
- NCT07062172 · 1,753 participants · NA
Lung Cancer Screening of Family Members of Patients With Mutation-Driven Lung Cancer
- NCT03067181 · 1,780 participants · Phase 3
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI